Foci Healthcare Announces Executive Leadership Changes

September 9, 2024 7:00 AM

Foci Healthcare today announced the appointment of Richard W. Pascoe as Chief Executive Officer. He brings more than 30 years of leadership experience with development- and commercial-stage biopharma companies and the proven ability to guide businesses through value-driven transformations. The Company also announced the resignation of Anthony Amato as Chief Executive Officer effective immediately.In his role, Pascoe will lead Foci's efforts to...

Read more

Global Clinical Risk Grouping Solutions Market Poised for Remarkable Growth reaching a valuation of USD 2380 Million by 2034, Driven by Emphasis on Social Determinants of Health

September 9, 2024 6:00 AM

The clinical risk grouping solutions market is on a trajectory of exceptional growth, with an estimated market share of USD 526.2 million in 2023. Projections indicate that this market is set to expand significantly, reaching a global valuation of USD 2380 million by 2034. This growth trajectory reflects a robust compound annual growth rate (CAGR) of 14.7% from 2024 to 2034.A key driver of this impressive market expansion is the growing focus on...

Read more

iZafe Group AB and Randstad Partner in Norway to Transform Medication Management and Drive Cost Savings for Municipalities

September 9, 2024 3:20 AM

STOCKHOLM, SE / ACCESSWIRE / September 09, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") today announces a strategic partnership with Randstad, a global leader in healthcare personnel services, to launch a new initiative in Norway. This collaboration aims to ensure the long-term and effective implementation of Dosell's medication dispensers across Norwegian municipalities by providing the right personnel with comprehensive...

Read more

Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson

September 9, 2024 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), a clinical-stage biopharmaceutical group focused on developing treatments for cancers and viral diseases, is pleased to announce the successful completion of the development of a clinical-grade assay ("Assay") designed to assess FLT3 protein expression in acute myeloid leukemia ("AML") cells.Assessing FLT3 protein expression in AML cells is crucial for the accurate identification and recruitment of...

Read more

Cantargia: New Data from Two Clinical Studies Strongly Support Nadunolimab Efficacy After Relapse on PD1-Inhibitors

September 8, 2024 6:15 PM

LUND, SE / ACCESSWIRE / September 8, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported data from two clinical trials including nadunolimab combination therapy in 55 cancer patients. Both trials show strong antitumor effects as well as very encouraging median survival times in patients previously treated with pembrolizumab. These clinical data combined with baseline biopsy analyses suggest a unique role...

Read more

Government Leaders to Detail Patient Harm Prevention Efforts at World Patient Safety Day Summit

September 8, 2024 2:07 PM

WASHINGTON, DC / ACCESSWIRE / September 8, 2024 / A quarter century after a landmark report galvanized government action on patient safety, senior federal health officials will be discussing ongoing efforts to reduce harm at a Sept. 17 event observing World Patient Safety Day sponsored by Patients for Patient Safety US (PFPS). The focus will be on the thousands of Americans harmed or killed by inaccurate diagnoses.In November 1999, a report by...

Read more

Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements

September 6, 2024 7:30 PM

Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it has received a formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Rule...

Read more

Alpha Dental Excellence Announces Monthly Dental Services Charity Program for Seniors in Pennsylvania

September 6, 2024 6:40 PM

Alpha Dental Excellence, a leading dental practice in Pennsylvania, is thrilled to announce the launch of its new Monthly Charity Dental Services Program, dedicated to enhancing the lives of seniors in the Greater Philadelphia area. Starting this month, Alpha Dental Excellence will provide complimentary dental services and procedures to seniors who are in need but face financial constraints. This initiative highlights the practice's ongoing...

Read more

VOESH New York Launches New 28 oz. Vegan Hand & Body Crème Collection

September 6, 2024 10:45 AM

NEW YORK, NY / ACCESSWIRE / September 6, 2024 / VOESH New York is debuting a new 28 oz. Vegan Hand & Body Crème Collection, created to provide salon clients with a luxurious and healthier hydration experience. These larger bottles offer the same high-quality, vegan-friendly ingredients that have established VOESH as a leader in the body care industry."We're thrilled about the addition of these generously sized lotions to VOESH's product line,"...

Read more

AGFA Healthcare to Demonstrate AI's New Role in Medical Imaging at Tampa General Hospital's First-Ever Innovation Week

September 6, 2024 10:30 AM

As part of Tampa General Hospital's Innovation Week's goal "to spark curiosity, creativity, and collaboration", AGFA HealthCare will present its latest AI innovation designed to streamline radiology workflows and enhance the delivery of patient care.TAMPA, FL / ACCESSWIRE / September 6, 2024 / AGFA HealthCare, a world-class innovator in Enterprise Imaging technology, will be offering a fascinating peek into healthcare imaging's exciting future...

Read more

EON Medical & Wellness: Revolutionizing Healthcare for the Hispanic Community with Innovative Telehealth Solutions

September 6, 2024 10:00 AM

TAMPA, FL / ACCESSWIRE / September 6, 2024 / EON Medical & Wellness, a trailblazer in the healthcare industry with a focus on the Hispanic and Latino community, is seeing an influx of patients after opening its doors just four months ago. This telehealth medical facility is bridging the gap in healthcare accessibility for Spanish-speaking patients in Florida and across the country. Founded by Italo Pignano, an innovative Italian-Peruvian...

Read more

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference

September 6, 2024 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / September 6, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will be presenting virtually, and meeting virtually with investors, at the H.C. Wainwright 26th Annual Global Investment Conference, which takes place September 9-11, 2024.Participation Instructions for Jaguar Health's Presentation at the H.C. Wainwright 26th Annual Global Investment...

Read more

Gilead Sciences: Living With a Rare Liver Disease: Maria's Journey

September 6, 2024 9:15 AM

NORTHAMPTON, MA / ACCESSWIRE / September 6, 2024 / In 2017, Maria Morais started to experience severe abdominal pain before eventually undergoing gall bladder surgery. When the procedure didn't bring her the relief she hoped for, follow-up tests showed her liver enzyme levels were abnormally high. Being a registered nurse, Maria knew something was wrong."I was also constantly tired. No matter how much I rested, it wasn't enough," she says.Maria...

Read more

Nomination Committee of XVIVO Perfusion AB (publ)

September 6, 2024 3:30 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / September 6, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The following members have been appointed to XVIVO Perfusion's nomination committee for the 2025 annual general meeting:Henrik Blomquist, appointed by Bure Equity ABThomas Ehlin, appointed by The Fourth Swedish National Pension FundMartin Lewin, appointed by Eccenovo ABGösta Johannesson, chairman of the board of directorsThe appointments have...

Read more

IRLAB Participates in the Event Investing in Life Science: From Seed to Success

September 6, 2024 1:20 AM

GOTHENBURG, SE / ACCESSWIRE / September 06, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 6, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will give a presentation at the event Investing in life science: From seed to success, in Stockholm on September 12, 2024.The event is hosted by Biostock...

Read more

Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024

September 5, 2024 4:05 PM

Dermata Therapeutics, Inc. (Nasdaq:DRMA; DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced it will be presenting at the H.C. Wainwright 26th Annual Global Investment Conference, being held September 9-11, 2024.The in-person venue for the event is the Lotte New York Palace Hotel in New York City located at 455 Madison Avenue....

Read more

LCF Georgia to Host the Second Annual Orgullo Latinx Pride Reception at Atlanta City Hall

September 5, 2024 4:00 PM

Celebrating Diversity and Culture: LCF Georgia's Orgullo Latinx Pride Reception Returns to Atlanta City HallATLANTA, GA / ACCESSWIRE / September 5, 2024 / The Latino Community Fund (LCF Georgia) is thrilled to announce its second annual Orgullo Pride Reception, celebrating Latinx LGBTQIA+ leaders and community members across Georgia. This free event will be held at Atlanta City Hall, located at 55 Trinity Ave SW, on September 27, 2024, from 7:00...

Read more

Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results

September 5, 2024 4:00 PM

PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 fourth quarter and full-year ended June 30, 2024.Quarter Ended June 30, 2024Net sales for the three months ended June 30, 2024 increased $4.4 million, or 41%, to $15.0 million from $10.6 million for the three months ended June 30, 2023, due primarily to increased revenue in the amount of $3.4 million from our largest customer. Specifically, the increase relates to...

Read more

PMD Device Solutions Secures Significant Sales Contract, Setting the Stage for Significant Growth in the US

September 5, 2024 1:30 PM

STOCKHOLM, SE / ACCESSWIRE / September 5, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (Ticker Symbol: PMDS), a leader in Digital Healthcare, is excited to announce a significant new sales contract with a leading cardiology clinic in the Eastern United States. This clinic, which has one provider serving over 1,500 Medicare patients, represents a key step forward for PMDS' expansion in the US market."This contract is an...

Read more

Leading San Antonio Medical Waste Disposal Company Confronts Rising Needlestick Injuries With Vital Guide

September 5, 2024 1:11 PM

The CDC reports that healthcare workers in the U.S. face an estimated 385,000 needlestick and sharps-related injuries every year.SAN ANTONIO, TX / ACCESSWIRE / September 5, 2024 / Facing an increase in needlestick injuries, BioMedical Waste Solutions, a prominent medical waste disposal company, with locations in San Antonio, TX, is actively working to let the public know about the hazards of improper medical waste disposal, particularly...

Read more